EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Elevation of the tumor marker CA19 ‐9 in a pancreatic cancer survivor with benign prostatic hyperplasia: A clinical case report

Steve D Pendry, Nimit Singhal, Eu-Ling Neo, Darren Foreman, Jean M Winter iD

Clinical Case Reports · 2024-06 · 12 (6)

DOI: 10.1002/ccr3.8929 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Case Reports, online erschienen am 24.05.2024. Verfasst von Steve D Pendry und 4 weiteren Autor:innen. Beteiligte Einrichtung: Flinders Health and Medical Research College of Medicine and Public Health Flinders University Bedford Park South Australia Australia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key Clinical Message Serum carbohydrate antigen 19‐9 (CA19‐9) is used for recurrence surveillance in patients with resected pancreatic ductal adenocarcinoma (PDAC). This report describes the association of increasing CA19‐9 in a male PDAC survivor with presence of prostatic hyperplasia. Unexplained elevation of CA19‐9 in male PDAC survivors might be attributable to benign prostatic conditions.

Schlagwörter

Stichwörter der Autor:innen

carbohydrate antigen 19‐9pancreatic ductal adenocarcinomaprostateprostate specific antigen

Autor:innen und Institutionen

  • Flinders Health and Medical Research College of Medicine and Public Health Flinders University Bedford Park South Australia Australia.
  • Cancer Centre, Royal Adelaide Hospital and School of Medicine The University of Adelaide Adelaide South Australia Australia.
  • Hepatopancreatobiliary Surgical Unit Flinders Medical Centre Bedford Park South Australia Australia.
  • Hepatobiliary Surgical Unit Royal Adelaide Hospital Adelaide South Australia Australia.
  • College of Medicine and Public Health Flinders University Bedford Park South Australia Australia.

ORCID-Profile: Jean M Winter

Zitieren

APA

Pendry, S. D., Singhal, N., Neo, E. L., Foreman, D., & Winter, J. M. (2024). Elevation of the tumor marker CA19 ‐9 in a pancreatic cancer survivor with benign prostatic hyperplasia: A clinical case report. Clinical Case Reports, 12(6). https://doi.org/10.1002/ccr3.8929

Vancouver

Pendry SD, Singhal N, Neo EL, Foreman D, Winter JM. Elevation of the tumor marker CA19 ‐9 in a pancreatic cancer survivor with benign prostatic hyperplasia: A clinical case report. Clinical Case Reports. 2024;12(6). doi:10.1002/ccr3.8929

BibTeX
@article{Pendry2024,
  author = {Pendry, Steve D and Singhal, Nimit and Neo, Eu-Ling and Foreman, Darren and Winter, Jean M},
  title = {Elevation of the tumor marker CA19 ‐9 in a pancreatic cancer survivor with benign prostatic hyperplasia: A clinical case report},
  journal = {Clinical Case Reports},
  year = {2024},
  volume = {12},
  number = {6},
  doi = {10.1002/ccr3.8929}
}
Kostenlos starten →